Friedrich Overkamp Selected Research

Friedrich Overkamp Research Topics

Disease

31	Breast Neoplasms (Breast Cancer) 04/2021 - 01/2008
10	Neoplasms (Cancer) 02/2021 - 04/2012
4	Triple Negative Breast Neoplasms 04/2021 - 10/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2012
3	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2012
2	Ovarian Neoplasms (Ovarian Cancer) 12/2019 - 03/2018
2	Vomiting 03/2018 - 12/2017
2	Nausea 03/2018 - 12/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Injection Site Reaction 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Diarrhea 01/2020
1	Intestinal Perforation 01/2020
1	Peritonitis 01/2020
1	Tinnitus 01/2020
1	Brain Neoplasms (Brain Tumor) 12/2018
1	Disease Progression 10/2018
1	Alopecia (Baldness) 03/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2013
1	Multiple Myeloma 04/2009

Drug/Important Bio-Agent (IBA)

9	Hormones (Hormone)IBA 04/2021 - 01/2011
4	pertuzumabIBA 11/2020 - 01/2019
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2020 - 03/2018
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 03/2018
2	Pharmaceutical PreparationsIBA 02/2021 - 12/2020
2	Ado-Trastuzumab EmtansineIBA 10/2020 - 10/2019
2	L-BLP25IBA 01/2020 - 04/2012
2	Trastuzumab (Herceptin)FDA Link 01/2019 - 12/2017
2	Tyrosine Kinase InhibitorsIBA 12/2017 - 01/2013
1	AlpelisibIBA 04/2021
1	sacituzumab govitecanIBA 04/2021
1	Phenobarbital (Luminal)FDA Link 04/2021
1	Immunoconjugates (Immunoconjugate)IBA 04/2021
1	larotrectinibIBA 02/2021
1	entrectinibIBA 02/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	histidine-rich proteinsIBA 11/2020
1	seribantumabIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 04/2020
1	Saline SolutionIBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2020
1	atezolizumabIBA 12/2019
1	Biological ProductsIBA 10/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	Carbonic Anhydrase IXIBA 01/2019
1	human ERBB2 proteinIBA 12/2018
1	PhosphoproteinsIBA 10/2018
1	neratinibIBA 12/2017
1	Sorafenib (BAY 43-9006)FDA Link 07/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2017
1	N,N'-bis(4-azidobenzoyl)cystineIBA 02/2016
1	taxaneIBA 01/2013
1	Everolimus FDA Link 01/2013
1	AnthracyclinesIBA 01/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Glycoproteins (Glycoprotein)IBA 04/2012
1	Fulvestrant (Faslodex)FDA Link 01/2011
1	Bortezomib (Velcade)FDA Link 04/2009

Therapy/Procedure

31	Therapeutics 04/2021 - 01/2008
4	Drug Therapy (Chemotherapy) 10/2019 - 12/2017
3	Immunotherapy 12/2019 - 04/2012
2	Neoadjuvant Therapy 01/2019 - 01/2013
2	Precision Medicine 11/2018 - 11/2018
1	Metastasectomy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 12/2019
1	Adjuvant Chemotherapy 12/2017
1	Complementary Therapies (Alternative Medicine) 05/2017
1	Pain Management 06/2016
1	Radiotherapy 06/2016